PLRX Live signaler | Maksimer profitt med Getagraph.com

KJøP 107990 min ago

@ $16.43

Utstedt: 14 feb 2024 @ 21:44

Avkastning: -26.39%

Forrige signal: feb 14 - 15:30

Forrige signal: Selg

Avkastning: 5.47 %

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 22:00):

Stats
Dagens volum	238 975
Gjennomsnittsvolum	371 556
Markedsverdi	729.25M
EPS	$-0.690 ( 2024-03-28 )
Neste inntjeningsdato	( $-0.770 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.40
ATR14	$0.0130 (0.11%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-23	Lefebvre Eric	Buy	42 900	Common Stock
2024-01-23	Lefebvre Eric	Buy	85 800	Stock Option (Right to Buy)
2024-01-23	Hull Hans	Buy	31 500	Common Stock
2024-01-23	Hull Hans	Buy	63 000	Stock Option (Right to Buy)
2024-01-23	Ouimette Mike	Buy	31 500	Common Stock

INSIDER POWER
67.14
Last 98 transactions
Buy: 2 502 892 \| Sell: 552 083

Volum Korrelasjon

Lang: 0.02 (neutral)

Kort: -0.39 (neutral)

Signal:(42.312) Neutral

Pliant Therapeutics Inc Korrelasjon

10 Mest positive korrelasjoner
PAIC	0.955
CSII	0.935
ADMS	0.932
RESN	0.927
HSKA	0.921
ZGNX	0.918
OLMA	0.915
NATI	0.914
IPW	0.912
SVAC	0.911

10 Mest negative korrelasjoner
NETE	-0.945
BOCH	-0.932
MMAC	-0.914
RAVN	-0.912
SHSP	-0.879
SBBP	-0.876
CFV	-0.873
AMRB	-0.869
ORMP	-0.869
AZTA	-0.861

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Pliant Therapeutics Inc Korrelasjon - Valuta/Råvare

-0.27
( neutral )

-0.17
( neutral )

0.00
( neutral )

-0.50
( neutral )

0.73
( moderate )

-0.54
( weak negative )

Pliant Therapeutics Inc Økonomi

Annual	2023
Omsetning:	$1.58M
Bruttogevinst:	$-261 000 (-16.52 %)
EPS:	$-2.75

FY	2023
Omsetning:	$1.58M
Bruttogevinst:	$-261 000 (-16.52 %)
EPS:	$-2.75

FY	2022
Omsetning:	$9.69M
Bruttogevinst:	$6.00M (61.99 %)
EPS:	$-2.89

FY	2021
Omsetning:	$7.57M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-2.71

Financial Reports:

No articles found.

Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor for treatment of muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.